OncoBeta reports 12-Month Results from International Phase IV Study for Non-Melanoma Skin Cancer

MUNICH, Aug. 13, 2025 /PRNewswire/ — OncoBeta® GmbH, a medical device company specialising in innovative epidermal radioisotope therapies, has announced 12-months interim results from its international Phase IV, multi-centre clinical trial evaluating the efficacy and safety of…